A Database Survey of Comparison The Risk of Haemorrhage Between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in Participants With Depression

NCT05932407 · clinicaltrials.gov ↗

COMPLETED

Status

147777

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Vortioxetine Tablet
DRUG: SSRI

Sponsor

Takeda